BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21180541)

  • 1. The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial.
    Shields WW; Thompson KE; Grice GA; Harrison SA; Coyle WJ
    Therap Adv Gastroenterol; 2009 May; 2(3):157-63. PubMed ID: 21180541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
    Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
    Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.
    Shavakhi A; Minakari M; Firouzian H; Assali R; Hekmatdoost A; Ferns G
    Int J Prev Med; 2013 May; 4(5):531-7. PubMed ID: 23930163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.
    Sharma BC; Kumar A; Garg V; Reddy RS; Sakhuja P; Sarin SK
    J Clin Exp Hepatol; 2012 Dec; 2(4):333-7. PubMed ID: 25755455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial.
    Torres DM; Jones FJ; Shaw JC; Williams CD; Ward JA; Harrison SA
    Hepatology; 2011 Nov; 54(5):1631-9. PubMed ID: 21748770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
    van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
    Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.
    Zang S; Chen J; Song Y; Bai L; Chen J; Chi X; He F; Sheng H; Wang J; Xie S; Xie W; Yang Y; Zhang J; Zheng M; Zou Z; Wang B; Shi J;
    Adv Ther; 2018 Feb; 35(2):218-231. PubMed ID: 29411270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial.
    Wen Q; Hu M; Lai M; Li J; Hu Z; Quan K; Liu J; Liu H; Meng Y; Wang S; Wen X; Yu C; Li S; Huang S; Zheng Y; Lin H; Liang X; Lu L; Mai Z; Zhang C; Wu T; Ng EHY; Stener-Victorin E; Ma H
    Hum Reprod; 2022 Mar; 37(3):542-552. PubMed ID: 34907435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report.
    Duseja A; Murlidharan R; Bhansali A; Sharma S; Das A; Das R; Chawla Y
    Indian J Gastroenterol; 2004; 23(1):12-5. PubMed ID: 15106708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
    Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
    Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.
    Bell LN; Wang J; Muralidharan S; Chalasani S; Fullenkamp AM; Wilson LA; Sanyal AJ; Kowdley KV; Neuschwander-Tetri BA; Brunt EM; McCullough AJ; Bass NM; Diehl AM; Unalp-Arida A; Chalasani N;
    Hepatology; 2012 Oct; 56(4):1311-8. PubMed ID: 22532269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
    Loomba R; Lutchman G; Kleiner DE; Ricks M; Feld JJ; Borg BB; Modi A; Nagabhyru P; Sumner AE; Liang TJ; Hoofnagle JH
    Aliment Pharmacol Ther; 2009 Jan; 29(2):172-82. PubMed ID: 18945255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin in nonalcoholic steatohepatitis: a randomized controlled trial.
    Kazemi R; Aduli M; Sotoudeh M; Malekzadeh R; Seddighi N; Sepanlou SG; Merat S
    Middle East J Dig Dis; 2012 Jan; 4(1):16-22. PubMed ID: 24829630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity.
    Lazar MV; Eapen M; Nair HR; Siyad I; Gopalakrishna R
    Indian J Gastroenterol; 2020 Feb; 39(1):42-49. PubMed ID: 32222944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis.
    Ćulafić M; Vezmar-Kovačević S; Dopsaj V; Oluić B; Bidžić N; Miljković B; Ćulafić Đ
    J Med Biochem; 2020 Sep; 39(3):290-298. PubMed ID: 33269017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.